survival. This consideration might help to determine pat- terns of recurrence and adequate therapeutic options for recurrent cholangiocarcinoma. CONFLICTS OF INTEREST No potential conflict of interest relevant to this article was reported. REFERENCES 1. Kwon OS, Jun DW, Kim SH, Chung MY, Kim NI, Song MH, et al. Distant skeletal muscle metastasis from intra- hepatic cholangiocarcinoma presenting as Budd-Chiari syndrome. World J Gastroenterol 2007;13:3141-3. 2. Tao LY, He XD, Qu Q, Cai L, Liu W, Zhou L, et al. Risk fac- tors for intrahepatic and extrahepatic cholangiocarcinoma: a case-control study in China. Liver Int 2010;30:215-21. 3. Park SK, Kim YS, Kim SG, Jang JY, Moon JH, Lee MS, et al. Detection of distant metastasis to skeletal muscle by 18F-FDG-PET in a case of intrahepatic cholangiocar- cinoma. Korean J Hepatol 2010;16:325-8. 4. Zhang KJ, Wang DS, Zhang SY, Jiao XL, Li CW, Wang XS, et al. The E-cadherin repressor slug and progression of hu- man extrahepatic hilar cholangiocarcinoma. J Exp Clin Cancer Res 2010;29:88. 5. Ito Y, Tajima Y, Fujita F, Tsutsumi R, Kuroki T, Kanematsu T. Solitary recurrence of hilar cholangiocarcinoma in a me- diastinal lymph node two years after curative resection. World J Gastroenterol 2007;13:2243-6. 6. Singal AG, Rakoski MO, Salgia R, Pelletier S, Welling TH, Fontana RJ, et al. The clinical presentation and prognostic factors for intrahepatic and extrahepatic cholangiocarci- noma in a tertiary care centre. Aliment Pharmacol Ther 2010;31:625-33. 7. Endo I, Gonen M, Yopp AC, Dalal KM, Zhou Q, Klimstra D, et al. Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg 2008;248:84-96. 8. Ito K, Ito H, Allen PJ, Gonen M, Klimstra D, D'Angelica MI, et al. Adequate lymph node assessment for extra- hepatic bile duct adenocarcinoma. Ann Surg 2010;251: 675-81. 9. Francis H, Alpini G, DeMorrow S. Recent advances in the regulation of cholangiocarcinoma growth. Am J Physiol Gastrointest Liver Physiol 2010;299:G1-9. 10. Tamandl D, Herberger B, Gruenberger B, Puhalla H, Klinger M, Gruenberger T. Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma. Ann Surg Oncol 2008;15:2787-94. Surgical treatments for recurrent cholangiocarcinoma 11. Yamamoto Y, Shimada K, Sakamoto Y, Esaki M, Nara S, Ban D, et al. Clinicopathological characteristics of intra- hepatic cholangiocellular carcinoma presenting intra- hepatic bile duct growth. J Surg Oncol 2009;99:161-5. 12. Saxena A, Chua TC, Sarkar A, Chu F, Morris DL. Clinicopathologic and treatment-related factors influenc- ing recurrence and survival after hepatic resection of intra- hepatic cholangiocarcinoma: a 19-year experience from an established Australian hepatobiliary unit. J Gastrointest Surg 2010;14:1128-38. 13. Shen FZ, Zhang BY, Feng YJ, Jia ZX, An B, Liu CC, et al. Current research in perineural invasion of cholangio- carcinoma. J Exp Clin Cancer Res 2010;29:24. 14. Park J, Kim MH, Kim KP, Park do H, Moon SH, Song TJ, et al. Natural history and prognostic factors of advanced cholangiocarcinoma without surgery, chemotherapy, or ra- diotherapy: a large-scale observational study. Gut Liver 2009;3:298-305. 15. Carrafiello G, Laganà D, Cotta E, Mangini M, Fontana F, Bandiera F, et al. Radiofrequency ablation of intrahepatic cholangiocarcinoma: preliminary experience. Cardiovasc Intervent Radiol 2010;33:835-9. 16. Nagahashi M, Shirai Y, Wakai T, Sakata J, Ajioka Y, Nomura T, et al. Depth of invasion determines the post- resectional prognosis for patients with T1 extrahepatic cholangiocarcinoma. Cancer 2010;116:400-5. 17. Kurosaki I, Hatakeyama K. Repeated hepatectomy for re- current intrahepatic cholangiocarcinoma: report of two cases. Eur J Gastroenterol Hepatol 2005;17:125-30. 18. Kamphues C, Seehofer D, Eisele RM, Denecke T, Pratschke J, Neumann UP, et al. Recurrent intrahepatic cholangio- carcinoma: single-center experience using repeated hep- atectomy and radiofrequency ablation. J Hepatobiliary Pancreat Sci 2010;17:509-15. 19. Kobayashi A, Miwa S, Nakata T, Miyagawa S. Disease re- currence patterns after R0 resection of hilar cholangio- carcinoma. Br J Surg 2010;97:56-64. 20. Sakamoto Y, Shimada K, Nara S, Esaki M, Ojima H, Sano T, et al. Surgical management of infrahilar/suprapancreatic cholangiocarcinoma: an analysis of the surgical proce- dures, surgical margins, and survivals of 77 patients. J Gastrointest Surg 2010;14:335-43. 21. Kim SJ, Lee CY, Kim DG. Analysis of the clinical outcome and prognostic factors of patients with hilar cholangio- carcinoma. J Korean Surg Soc 2007;73:156-64. 22. Takahashi Y, Nagino M, Nishio H, Ebata T, Igami T, Nimura Y. Percutaneous transhepatic biliary drainage catheter tract recurrence in cholangiocarcinoma. Br J Surg 2010;97:1860-6. 23. Stergiopoulos C, Kountouras J, Kapetanakis N, Katsinelos P, Kokkali S, Tsapournas G, et al. Distant cutaneous meta- stasis preceding the diagnosis of ductal cholangiocar- cinoma. J Eur Acad Dermatol Venereol 2009;23:242-3. 24. Ohtsuka M, Kimura F, Shimizu H, Yoshidome H, Kato A, Yoshitomi H, et al. Significance of repeated resection for re- current intrahepatic cholangiocarcinoma. Hepatogastroen- terology 2009;56:1-5. thesurgery.or.kr 193